Back to 
Aviva plc
Aviva plc
RYTM
Showing 0 of 5 quarters
Position history for Aviva plc's holdings in Rhythm Pharmaceuticals, Inc.
No. Aviva exited its RYTM (Rhythm Pharmaceuticals) position in Q1 2021. Its Q4 2020 13F listed 48,218 shares worth $1.4M. Aviva first reported RYTM in Q1 2020 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.